Skip to Content


In the US, Dolasetron (dolasetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Nausea/Vomiting - Chemotherapy Induced and Nausea/Vomiting - Postoperative.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiemetic agent

Serotonin 5HT₃-receptor antagonist

Chemical Name

1H-Indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2α,6α,8α,9aβ)-

Foreign Names

  • Dolasetronum (Latin)
  • Dolasetron (German)
  • Dolasétron (French)
  • Dolasetron (Spanish)

Generic Names

Brand Names

  • Anemet
    Sanofi-Aventis, Germany
  • Anzemet
    Han Dok, South Korea; Sanofi-Aventis, Australia; Sanofi-Aventis, Bulgaria; Sanofi-Aventis, Mexico
  • Zamanon
    Sanofi-Aventis, South Africa
  • Anzemet
    sanofi-aventis, United States

International Drug Name Search


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.